-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Heron Therapeutics, Inc. /De/ Operating Income (Loss) for the quarter ending March 31, 2024 was -$4.8 M, a 85.5% increase year-over-year.
- Heron Therapeutics, Inc. /De/ Operating Income (Loss) for the twelve months ending March 31, 2024 was -$82.4 M, a 43.1% increase year-over-year.
- Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2023 was -$111 M, a 36.7% increase from 2022.
- Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2022 was -$175 M, a 19.8% increase from 2021.
- Heron Therapeutics, Inc. /De/ annual Operating Income (Loss) for 2021 was -$218 M, a 4.53% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)